HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ubaldo Bonuccelli Selected Research

Disorders of Excessive Somnolence (Hypersomnia)

1/2020Progressive loss of raphe nuclei serotonin transporter in early Parkinson's disease: A longitudinal 123I-FP-CIT SPECT study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ubaldo Bonuccelli Research Topics

Disease

63Parkinson Disease (Parkinson's Disease)
05/2022 - 01/2002
23Alzheimer Disease (Alzheimer's Disease)
04/2022 - 11/2005
14Dementia (Dementias)
04/2022 - 09/2006
11Cognitive Dysfunction
04/2022 - 05/2009
11Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 05/2003
8Dyskinesias (Dyskinesia)
01/2017 - 01/2002
7Parkinsonian Disorders (Parkinsonism)
05/2022 - 11/2006
6Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
11/2014 - 11/2010
5Migraine Disorders (Migraine)
10/2019 - 07/2015
5Tremor (Tremors)
01/2018 - 10/2008
4Hallucinations (Hallucination)
07/2014 - 07/2007
3Huntington Disease (Huntington's Disease)
11/2020 - 10/2008
3Frontotemporal Dementia (Semantic Dementia)
01/2020 - 09/2017
3Pain (Aches)
10/2019 - 09/2008
3Corticobasal Degeneration
01/2019 - 05/2011
3Synucleinopathies
01/2019 - 10/2017
3Disease Progression
05/2015 - 10/2006
3Sleepiness
01/2015 - 12/2003
3Multiple System Atrophy
01/2008 - 10/2003
2Lewy Body Disease (Lewy Body Dementia)
01/2021 - 01/2015
2Dystonia (Limb Dystonia)
01/2019 - 03/2002
2Epilepsy (Aura)
01/2017 - 11/2014
2Fatigue
12/2015 - 01/2015
2Hyperhomocysteinemia
07/2015 - 05/2009
2Headache (Headaches)
07/2015 - 09/2010
2Multiple Sclerosis
06/2015 - 01/2015
2Stroke (Strokes)
11/2014 - 10/2010
2Psychotic Disorders (Schizoaffective Disorder)
10/2014 - 07/2007
2Mental Disorders (Mental Disorder)
02/2013 - 07/2007
2Neurologic Manifestations (Neurological Manifestations)
11/2011 - 09/2002
2Gambling (Pathological Gambling)
02/2011 - 11/2010
2Fibrosis (Cirrhosis)
10/2007 - 01/2002
1Anxiety Disorders (Anxiety Disorder)
05/2021
1Aphasia (Dysphasia)
04/2021
1Normal Pressure Hydrocephalus
02/2021
1Neuroinflammatory Diseases
01/2021
1Inflammation (Inflammations)
01/2021
1Ataxia (Dyssynergia)
11/2020
1Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
11/2020
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
11/2020
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2020
1Disorders of Excessive Somnolence (Hypersomnia)
01/2020
1Epileptic Syndromes
11/2019
1Generalized Epilepsy
11/2019
1Partial Epilepsies (Epilepsy, Partial)
11/2019
1Juvenile Myoclonic Epilepsy
11/2019

Drug/Important Bio-Agent (IBA)

22Levodopa (L Dopa)FDA LinkGeneric
05/2022 - 01/2002
18Dopamine Agonists (Dopamine Agonist)IBA
01/2016 - 01/2002
17Biomarkers (Surrogate Marker)IBA
11/2020 - 10/2003
11Pharmaceutical PreparationsIBA
01/2021 - 01/2003
82- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
01/2021 - 04/2007
8Amyloid (Amyloid Fibrils)IBA
01/2021 - 01/2017
7Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
05/2022 - 04/2007
6Proteins (Proteins, Gene)FDA Link
11/2020 - 01/2017
6Dopamine (Intropin)FDA LinkGeneric
01/2018 - 11/2010
5AntioxidantsIBA
04/2022 - 11/2005
5SynucleinsIBA
01/2021 - 01/2018
5Mitochondrial DNA (mtDNA)IBA
11/2014 - 06/2005
5ropinirole (Requip)FDA LinkGeneric
11/2014 - 12/2003
5Pergolide (Permax)FDA Link
12/2009 - 01/2002
4IronIBA
01/2019 - 09/2002
4ApomorphineFDA Link
01/2015 - 03/2002
4Dopamine Agents (Dopaminergic Agents)IBA
10/2013 - 01/2003
4CabergolineFDA LinkGeneric
12/2009 - 01/2003
3Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2020 - 07/2007
3Type A Botulinum Toxins (Botox)FDA Link
01/2019 - 12/2015
3Amyloid beta-PeptidesIBA
01/2018 - 07/2015
3Pramipexole (Mirapex)FDA LinkGeneric
10/2013 - 12/2003
2EnzymesIBA
01/2021 - 11/2012
2Neuroprotective AgentsIBA
05/2020 - 01/2017
2LipidsIBA
09/2019 - 01/2019
2diazonaphthalenedisulfonic acid (NDS)IBA
01/2018 - 01/2018
2tau Proteins (tau Protein)IBA
10/2017 - 01/2017
2DNA (Deoxyribonucleic Acid)IBA
01/2016 - 07/2015
2HomocysteineIBA
07/2015 - 05/2009
2Sulfhydryl Compounds (Thiols)IBA
07/2015 - 01/2015
2Advanced Oxidation Protein Products (AOPP)IBA
07/2015 - 01/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
07/2015 - 02/2013
2AnticoagulantsIBA
09/2013 - 07/2010
2ElectrolytesIBA
09/2010 - 07/2010
2Arginine (L-Arginine)FDA Link
01/2008 - 11/2006
2Growth Hormone (Somatotropin)IBA
01/2008 - 11/2006
2Clozapine (Clozaril)FDA LinkGeneric
05/2004 - 03/2002
1Antidepressive Agents (Antidepressants)IBA
05/2021
1SandIBA
04/2021
1InflammasomesIBA
01/2021
1ImmunosorbentsIBA
01/2021
1Purinergic P2X7 ReceptorsIBA
01/2021
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2021
1Tetrabenazine (Nitoman)FDA Link
11/2020
1ProgranulinsIBA
01/2020
1Apolipoproteins E (ApoE)IBA
11/2019
1ApolipoproteinsIBA
11/2019
1Immunoglobulin E (IgE)IBA
11/2019
1Neurotransmitter Agents (Neurotransmitter)IBA
10/2019

Therapy/Procedure

23Therapeutics
10/2020 - 01/2002
2Denervation
07/2015 - 07/2014
1Ventriculoperitoneal Shunt
02/2021
1Transcranial Direct Current Stimulation
01/2021
1Electrodes (Electrode)
01/2021